PDE4A and lymphoma: In this instance, by controlling the expression of cell intrinsic pro-angiogenic factors (VEGF-A, MYC and HIF1α) or by directly inhibiting endothelial cells in the tumor microenvironment, we found that PDE4 inhibition meaningfully suppressed lymphoma angiogenesis [16,17].